Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Citi
Baxter
US Department of Justice
Daiichi Sankyo
Merck
Covington
Harvard Business School
Fish and Richardson
Farmers Insurance

Generated: December 11, 2017

DrugPatentWatch Database Preview

Amitriptyline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for amitriptyline hydrochloride and what is the scope of amitriptyline hydrochloride freedom to operate?

Amitriptyline hydrochloride
is the generic ingredient in eighteen branded drugs marketed by Roche, Watson Labs, Astrazeneca, Bristol Myers Squibb, Warner Chilcott, Accord Hlthcare, Am Therap, Ani Pharms Inc, Copley Pharm, Halsey, Lederle, Mutual Pharm, Mylan, Par Pharm, Pliva, Purepac Pharm, Roxane, Sandoz, Sun Pharm Inds Inc, Superpharm, Teva, Ucb Inc, Usl Pharma, Vangard, Vintage Pharms, West Ward, Zydus Pharms Usa Inc, Anda Repository, Mylan Pharms Inc, Watson Labs Teva, Heritage Pharms Inc, Schering, Ivax Sub Teva Pharms, Sun Pharm Industries, and New River, and is included in one hundred and seventy-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for amitriptyline hydrochloride. Forty-three suppliers are listed for this compound.

Pharmacology for amitriptyline hydrochloride

Medical Subject Heading (MeSH) Categories for amitriptyline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Watson LabsPERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEamitriptyline hydrochloride; perphenazineTABLET;ORAL070376-001Aug 25, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Accord HlthcareAMITRIPTYLINE HYDROCHLORIDEamitriptyline hydrochlorideTABLET;ORAL202446-006Jun 4, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncAMITRIPTYLINE HYDROCHLORIDEamitriptyline hydrochlorideTABLET;ORAL089399-003Jul 14, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AstrazenecaELAVILamitriptyline hydrochlorideTABLET;ORAL012703-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozPERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEamitriptyline hydrochloride; perphenazineTABLET;ORAL071863-001Dec 21, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Vintage PharmsAMITRIPTYLINE HYDROCHLORIDEamitriptyline hydrochlorideTABLET;ORAL040218-001Sep 11, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncAMITRIPTYLINE HYDROCHLORIDEamitriptyline hydrochlorideTABLET;ORAL210086-004Oct 6, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaAMITRIPTYLINE HYDROCHLORIDEamitriptyline hydrochlorideTABLET;ORAL086610-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Vintage PharmsAMITRIPTYLINE HYDROCHLORIDEamitriptyline hydrochlorideTABLET;ORAL040218-004Sep 11, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
RoxaneAMITRIPTYLINE HYDROCHLORIDEamitriptyline hydrochlorideTABLET;ORAL086002-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: amitriptyline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AstrazenecaELAVILamitriptyline hydrochlorideTABLET;ORAL012703-007Approved Prior to Jan 1, 1982► Subscribe► Subscribe
AstrazenecaELAVILamitriptyline hydrochlorideINJECTABLE;INJECTION012704-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
AstrazenecaELAVILamitriptyline hydrochlorideTABLET;ORAL012703-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
AstrazenecaELAVILamitriptyline hydrochlorideTABLET;ORAL012703-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
AstrazenecaELAVILamitriptyline hydrochlorideTABLET;ORAL012703-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
AstrazenecaELAVILamitriptyline hydrochlorideTABLET;ORAL012703-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
AstrazenecaELAVILamitriptyline hydrochlorideTABLET;ORAL012703-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
US Department of Justice
Deloitte
Moodys
Healthtrust
Merck
Baxter
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot